Hillstream BioPharma, Inc. HILS NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

Il y a eu 37 transactions d'initiés récentes enregistrées pour Hillstream BioPharma, Inc. (HILS), dont 17 achats et 17 ventes. Le total des achats d'initiés s'élève à $246.81K et le total des ventes d'initiés à $654.79K.

Les initiés notables ayant une activité récente comprennent Milby Randy, Mazur Leonard L, Anderson Kelly. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — HILS

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2023-12-15	Milby Randy	CEO	Achat Informatif	29,000	$0.50	$14.59K	156,517
2023-11-30	Milby Randy	CEO	Achat Informatif	10,000	$1.00	$10K	127,517
2023-11-07	Mazur Leonard L	Director	Attribution de RSU	25,000	$0.16	$3.94K	25,000
2023-11-07	Anderson Kelly	Director	Attribution de RSU	50,000	$0.16	$7.89K	50,000
2023-11-07	Appajosyula Sireesh	Director	Attribution de RSU	25,000	$0.16	$3.94K	25,000
2023-11-07	Bui Lynne A.	Director	Attribution de RSU	25,000	$0.16	$3.94K	25,000
2023-05-09	Anderson Kelly	Director	Inconnu	-	-	-	-
2023-01-01	Milby Randy	Chief Executive Officer	Attribution de RSU	621,795	-	-	621,795
2023-01-01	Milby Randy	10 Percent Owner, Officer: Chief Executive Officer	Attribution de RSU	515,127	$0.39	$200.9K	515,127
2022-07-14	Appajosyula Sireesh	Director	Don (Donné)	75,757	-	-	-
2022-06-17	Milby Randy	Chief Executive Officer	Achat Informatif	500	$0.78	$389.95	2,937,940
2022-06-06	Milby Randy	Chief Executive Officer	Achat Informatif	234	$0.68	$160.27	2,937,774
2022-06-01	Milby Randy	Chief Executive Officer	Achat Informatif	1	$0.94	$0.94	2,937,540
2022-05-25	Milby Randy	Chief Executive Officer	Achat Informatif	200	$0.77	$154.00	2,936,739
2022-05-20	Milby Randy	Chief Executive Officer	Achat Informatif	500	$0.89	$445.00	2,936,039
2022-05-19	Milby Randy	Chief Executive Officer	Achat Informatif	500	$0.92	$457.65	2,935,039
2022-04-18	Milby Randy	Chief Executive Officer	Exercice d'Options (ITM)	189,393	$0.08	$14.96K	-
2022-03-21	Mazur Leonard L	Director	Attribution de RSU	50,000	-	-	50,000
2022-03-21	Appajosyula Sireesh	Director	Attribution de RSU	50,000	-	-	50,000
2022-03-21	Bui Lynne A.	Director	Attribution de RSU	50,000	-	-	50,000
2022-01-14	Mazur Leonard L	Director	Conversion (Vente)	-	$3.20	-	-
2022-01-14	Milby Randy	Chief Executive Officer	Conversion (Vente)	-	$3.20	-	-
2022-01-11	Mazur Leonard L	Director	Cession	-	-	-	-
2022-01-11	Hess Thomas	Officer	Inconnu	-	-	-	-
2022-01-11	Laumas Sandeep	10 Percent Owner	Cession	-	-	-	-
2022-01-11	Appajosyula Sireesh	Director	Cession	37,878	$0.08	$3K	-
2022-01-11	Bui Lynne A.	Director	Cession	18,939	$13.20	$249.99K	-
2022-01-11	Kharbanda Surender	10 Percent Owner	Cession	946	$7.82	$7.4K	-
2022-01-11	Highpoint Pharmaceuticals Llc	10 Percent Owner	Cession	-	-	-	972,222
2022-01-11	Milby Randy	Chief Executive Officer	Cession	37,878	$2.64	$100K	-
2022-01-11	Kufe Llc	10 Percent Owner	Cession	-	-	-	-
2022-01-11	Milby Randy	10 Percent Owner, Officer: Chief Executive Officer	Cession	-	-	-	1,772,725
2022-01-11	Kaur Varinder	10 Percent Owner	Cession	-	-	-	653,059
2022-01-11	Milby Randy	Chief Executive Officer	Cession	37,878	$2.64	$100K	-
2021-05-31	Milby Randy	Chief Executive Officer	Cession	18,939	$7.82	$148.14K	-
2020-12-31	Milby Randy	Chief Executive Officer	Cession	7,575	$3.82	$28.91K	-
2020-09-30	Milby Randy	Chief Executive Officer	Cession	7,575	$0.31	$2.38K	-

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration